My questions:
1. The Company has been stating that they are in advanced discussions with major pharma's regarding the canine lymphoma trials. Have any of these major pharma's indicated what milestone PAA need to achieve for them to pull the trigger? ie; successful completion of Phase II, Phase III etc?
2. Who is drafting the announcements to the market? As @Mickey Mouse mentioned, their announcements provide more questions than they do answers! I find myself having to read the announcement 10 times and to research things they mention so I can make some sense of it.
3. What are the next milestones we should expect to hear about and provide an estimated timeframe for each. Not that timeframes ever get hit due to outside issues but it would be good to know.
Who wants a Zoom Meeting with Management, page-11
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $109.4M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $142.9K | 621.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11933 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 174498 | 6 |
View Market Depth
| Last trade - 15.09pm 16/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |